BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8383827)

  • 1. Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancer.
    Paradiso A; Ventrella V; Farchi G; Tommasi S; Mangia A; Barletta A; Schittulli F; Racanelli A; De Lena M
    Oncology; 1993; 50(2):104-9. PubMed ID: 8383827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cell receptors and proliferation markers in breast cancer].
    Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
    Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
    Ronay G; Sponsel N; Tulusan AH
    Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progesterone receptors in breast cancer. Comparison of immunohistochemical with biochemical receptor analysis. Relation between hormone receptor content and growth fraction (Ki-67)].
    Ronay G; Sponsel N; Merkle E; Tulusan AH
    Pathologe; 1990 Jan; 11(1):4-9. PubMed ID: 2156252
    [No Abstract]   [Full Text] [Related]  

  • 5. [The relationship between the receptor status and the mammographic picture in operable breast cancer].
    Ventrella V; Paradiso A; Farchi G; Tommasi S; Schittulli F; Racanelli A; De Lena M
    Radiol Med; 1990 May; 79(5):483-8. PubMed ID: 2359855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between proliferative activity and cellular hormono-dependence in the MCF-7 breast cancer cell line.
    del Moral R; Ruiz de Almodóvar JM; Fernández JC; López-González JD; Villalba J; Olea N; Pedraza V
    Rev Esp Fisiol; 1990 Sep; 46(3):247-53. PubMed ID: 1965340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic targeting in breast cancer].
    Penault-Llorca F
    Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between mammographic features and hormone receptor content in patients with breast cancer.
    Ainge GR; Choplin RH; Bechtold RE; Muss HB; Case LD; Kute TE
    South Med J; 1989 Dec; 82(12):1506-11. PubMed ID: 2688129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathology and classification of malignant breast tumors].
    Bässler R
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):973-80. PubMed ID: 1663676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of the proliferative activity of breast cancer for prognosis and therapy].
    Pickartz H
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):993-4. PubMed ID: 1776291
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer: reliability of mammographic appearance as a predictor of hormone receptor status.
    Ciatto S; Morrone D; Catarzi S; Bonardi R
    Radiology; 1992 Mar; 182(3):805-8. PubMed ID: 1311118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
    Kasch R; Meissner J; Haack D; Neumann S
    Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor properties of primary tumors and local recurrence of breast cancer].
    Torsten U; Opri F; Moreno-Richter I; Weitzel HK
    Zentralbl Gynakol; 1993; 115(3):99-104. PubMed ID: 8385409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracystic papillary carcinoma of the breast: report of three cases].
    El mazghi A; Bouhafa T; Loukili K; El kacemi H; Lalya I; Kebdani T; Hassouni K
    Pan Afr Med J; 2014; 18():207. PubMed ID: 25419333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A correlative study of sex hormonal receptor status and mammographic appearance in primary breast cancer].
    He ZY
    Zhonghua Fang She Xue Za Zhi; 1989 Dec; 23(6):350-3. PubMed ID: 2560700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery].
    Seifert M; Wierrani F; Kubista E; Spona J
    Gynakol Rundsch; 1991; 31 Suppl 2():397-8. PubMed ID: 1790992
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sebaceous breast carcinoma: report of a rare histological special subtype].
    Wachter DL; Rauh C; Wenkel E; Fasching PA; Beckmann MW; Hartmann A
    Pathologe; 2014 Feb; 35(1):72-6. PubMed ID: 24414613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen dependence of primary breast cancer--correlation with histologic type and grade.
    Nikolić-Vukosavljević D; Branković-Magić M; Polić D; Vlajić M; Vuletić L; Spuzić I
    Neoplasma; 1992; 39(5):299-304. PubMed ID: 1436244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.